97183 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
ANTIBODY VACCINE CONJUGATES AND USES THEREFOR
#902Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1)
#903ANTIBODY PRODUCED USING OSTRICH AND METHOD FOR PRODUCTION THEREOF
#904Hybridoma capable of producing anti-dectin-1 monoclonal antibody
#905Immunoconjugates with an intracellularly-cleavable linkage
#906Antigen uptake receptor for candida albicans on dendritic cells
#907IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS
#908Recombinant production of mixtures of antibodies
#909Methods of identifying anti-inflammatory compounds
#910Use of CD23 Antibodies to Treat Malignancies in Patients with Poor Prognosis
#911Stimulation of Toll-Like Receptors on T Cells
#912Monoclonal antibodies against NKG2A
#913Genetically modified non-human mammals and cells
#914Methods and compositions for generating bioactive assemblies of increased complexity and uses
#915METHODS FOR BLOCKING THE INTERACTION BETWEEN NKP80 AND ITS LIGANDS
#916Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
#917Single-Chain Multivalent Binding Proteins with Effector Function
#918CD23 BINDING MOLECULES AND METHODS OF USE THEREOF
#919PROPHYLACTIC/THERAPEUTIC AGENT FOR CANCER
#920Methods and compositions for inhibiting CD32B expressing cells
#921NOVEL P-SELECTIN LIGAND PROTEIN
#922Methods, systems and reagents for improved immunodetection
#923Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#924ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS
#925GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#926COMPOSITIONS COMPRISING DC-SIGN BLOCKERS AND METHODS OF USING DC-SIGN BLOCKERS FOR PREVENTING OR TREATING DISEASES OF A MAMMAL, INCLUDING VIRAL INFECTIONS
#927Stabilized polypeptide compositions
#928Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
#929Modified binding molecules comprising connecting peptides
#930P-selectin ligand protein
#931GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#932Self-Buffering Protein Formulations
#933Compositions and methods for identifying response targets and treating flavivirus infection responses
#934Nucleic acids encoding P-selectin ligand fusion proteins
#935HLA-E BINDING
#936Compositions and methods for treating proliferative disorders
#937Modulation of Nkg2d
#938Activation of Human Antigen-Presenting Cells Through CLEC-6
#939Methods for inhibiting the binding of endosialin to ligands
#940Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
#941Therapeutic Applications of Activation of Human Antigen-Presenting Cells Through Dectin-1
#942IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#943IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#944USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#945Bispecific molecules cross-linking ITIM and ITAM for therapy
#946USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#947USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#948GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#949USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#950Compositions and methods for diagnosing and treating cancer
#951Composition and method for modulating dendritic cell-t cell interaction
#952Method of reducing the activation of Th2 lymphocytes
#953Stabilized polypeptide compositions
#954Glycosylated polypeptides produced in yeast mutants and methods of use thereof
#955Galectin 11
#956TUMOR ASSOCIATION OF MDL-1 AND METHODS
#957Compositions and Methods for Treating Proliferative Disorders Such as Nk-Type Ldgl
#958Targeting adenoviral vectors to dendritic cells
#959Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
#960Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
#961Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
#962Medicinal composition for treatment of chronic hepatitis c
#963Methods and compositions for generating bioactive assemblies of increased complexity and uses
#964Recombinant production of mixtures of antibodies
#965Activation of Lymphocyte Populations Expressing NKG2D Using Anti-NKG2D Antibodies and Ligand Derivatives
#966METHODS AND REAGENTS FOR THE ANALYSIS AND PURIFICATION OF POLYSACCHARIDES
#967Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics
#968Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics
#969Methods and compositions for the treatment of meconium aspiration syndrome
#970Biological products
#971Recombinant production of mixtures of antibodies
#972Use of biomolecular targets in the treatment and visualization of brain tumors
#973Endothelial cell specific antibodies and uses thereof
#974Immunoregulatory Antibodies and Uses Thereof
#975L-SIGN polymorphisms and methods involving use of same
#976Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#977Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#978Modulation of NKG2D for treating or preventing solid organ allograft rejection
#979Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
#980Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
#981Antibodies with immune effector activity and that internalize in endosialin-positive cells
#982Enduring T cell response
#983Method for isolating BDCA-4+ dendritic cells
#984Antigen uptake receptor for on dendritic cells
#985Binding molecules for the treatment of myeloid cell malignancies
#986USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#987Dc-sign blockers and their use for preventing or treating viral infections
#988Use of endosialin binding proteins to isolate endosialin positive cells
#989Methods of identifying and isolating cells expressing DC-sign
#990Tumor association of MDL-1 and methods
#991Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#992Galectin 11
#993Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
#994Composition and method for modulating dendritic cell-T cell interaction
#995Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
#996Antibody vaccine conjugates and uses therefor
#997Recombinant production of mixtures of antibodies
#998Identification of etiology of autism
#999Purification and preferential synthesis of binding molecules
#1000Modified binding molecules comprising connecting peptides
#1001Production of tetravalent antibodies
#1002Methods and compositions for treating autoimmune diseases or conditions
#1003Antibodies to mammalian langerhans cell antigen and their uses
#1004Lipoparticles comprising proteins, methods of making, and using the same
#1005Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
#1006Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#1007Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
#1008Composition and method for modulating dendritic cell-T cell interaction
#1009Methods of treating sickle cell disease
#1010Removal of high molecular weight aggregates using hydroxyapatite chromatography
#1011Composition and methods for treatment asthma
#1012Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#1013Immune regulation based on the depletion of CD69+ cells
#1014Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof
#1015Epsigam fusion protein
#1016Epsigam fusion protein
#1017Antibody vaccine conjugates and uses therefor